News Release

Iga City and ROHTO Pharmaceutical Co., Ltd. conclude a comprehensive cooperation agreement.

Rohto has revised the standards for its unique “R・eco” mark

We have entered into a capital alliance and licensing agreement with S-Alpha, a startup developing therapeutic apps.

Announcement Regarding Investment in FiNC Technologies Co., Ltd.

Further accelerating our health initiatives, which form the foundation of well-being, we have been certified as a "Certified Health & Productivity Management Outstanding Organization 2024 (White 500)".

The "DEOCO" hair care line for adult women's odor care has been renewed. It now incorporates the latest research on the "sweet scent" unique to young women!

Rohto Lycee Glow, a new eye cream that soothes tired eyes with a tiny drop that won't spill easily.

A new method for evaluating the impact of sunscreen formulations on coral growth has been established.

We have entered into a capital alliance with InnoJin, a university-born startup working on digital transformation in healthcare.

The "2023 Fertility Treatment White Paper" has been released. More than half of young unmarried men and women do not want children. About one in four women are "preparing for fertility treatment," keeping the option of pregnancy and childbirth open.